標(biāo)題: Titlebook: Establishing a Hematopoietic Stem Cell Transplantation Unit; A Practical Guide éliane Gluckman,Dietger Niederwieser,Mahmoud Aljur Book 2018 [打印本頁(yè)] 作者: 令人不愉快 時(shí)間: 2025-3-21 17:15
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit影響因子(影響力)
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit被引頻次
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit被引頻次學(xué)科排名
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit年度引用
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit年度引用學(xué)科排名
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit讀者反饋
書(shū)目名稱(chēng)Establishing a Hematopoietic Stem Cell Transplantation Unit讀者反饋學(xué)科排名
作者: 合唱團(tuán) 時(shí)間: 2025-3-21 22:15
General Principles of HSCT,000 patients per year, and worldwide activity continues to increase steadily. For many hematological and non-hematological diseases HSCT remains the only curative treatment option. Improved understanding of the immunological mechanisms of tolerance and anti-tumor reactivity has markedly reduced tran作者: Lasting 時(shí)間: 2025-3-22 02:58
The HSCT Program Structure: Minimal Requirements,key components that need to be in place for an HCT program are dependent on several factors that stem from the diseases being treated and consequently the types of transplants being performed; autologous, allogeneic, or both. These factors include the available infrastructure, ancillary services fro作者: sperse 時(shí)間: 2025-3-22 06:44 作者: 殘忍 時(shí)間: 2025-3-22 11:37 作者: 宣誓書(shū) 時(shí)間: 2025-3-22 14:48 作者: 宣誓書(shū) 時(shí)間: 2025-3-22 17:40 作者: Mnemonics 時(shí)間: 2025-3-22 22:58 作者: humectant 時(shí)間: 2025-3-23 01:22 作者: BRAVE 時(shí)間: 2025-3-23 08:22 作者: GRE 時(shí)間: 2025-3-23 11:26 作者: BURSA 時(shí)間: 2025-3-23 14:44 作者: 終止 時(shí)間: 2025-3-23 19:01 作者: 法律的瑕疵 時(shí)間: 2025-3-23 23:18 作者: 畫(huà)布 時(shí)間: 2025-3-24 05:44 作者: MAPLE 時(shí)間: 2025-3-24 08:34
Long-Term Follow-Up Program,e, which is best provided by a well-structured multispecialty long-term follow-up program (LTFU) program. Implementation and organization of an LTFU program for better care provision to survivors should be the responsibility of institutions with established transplant centers. Providers who are part作者: 消滅 時(shí)間: 2025-3-24 13:14 作者: Polydipsia 時(shí)間: 2025-3-24 15:31 作者: 極端的正確性 時(shí)間: 2025-3-24 22:57
,HSCT Center’s Success is Dependent upon Adequate Staff Education and Training,fective for sufferers of many malignant and non-malignant blood diseases. Studies indicate the success of HSCT is dependent on the experience of the transplant center, showing that well-trained and committed staff are an indispensable resource. Currently, there is no internationally accepted educati作者: Original 時(shí)間: 2025-3-25 00:19
General Principles of HSCT,splant-related mortality and has led to new techniques that enable HSCT in patients who lack a matched related donor. Further work will be required to reduce relapse incidence. In this chapter we describe the general principles of HSCT in a historical context, pointing out the requirements for establishing an HSCT unit and new developments.作者: Leisureliness 時(shí)間: 2025-3-25 03:27
Indications for Allogeneic Hematopoietic Stem Cell Transplantation in Adults, autologous HCT. Non-relapse mortality, while steadily declining, remains a challenge. The general principles, indications, and optimal timing of allogeneic HCT for malignant and non-malignant hematological disorders are discussed in this chapter.作者: 排斥 時(shí)間: 2025-3-25 10:47 作者: 卵石 時(shí)間: 2025-3-25 14:05
Introduction: Critically Distant,o support clinical decision-making, leading to best patient care. In this chapter, we discuss the key steps in the establishment of an effective HSCT database and present the main international HSCT registries and donor registries, as well as outlining increases in HSCT data collection and registration worldwide.作者: EVICT 時(shí)間: 2025-3-25 16:27
https://doi.org/10.1007/978-3-031-35561-5institutions in developed countries. Increasing public awareness of and patient education about essential hygiene measures and infection-control measures, and providing social services to enhance patient and family compliance are important additional factors to consider while planning for a successful HSCT program in developing countries.作者: 使入迷 時(shí)間: 2025-3-25 23:52 作者: 參考書(shū)目 時(shí)間: 2025-3-26 01:28
Hematopoeitic Stem Cell Transplantation Outcome Data Management: Importance of Establishing an Insto support clinical decision-making, leading to best patient care. In this chapter, we discuss the key steps in the establishment of an effective HSCT database and present the main international HSCT registries and donor registries, as well as outlining increases in HSCT data collection and registration worldwide.作者: 膠水 時(shí)間: 2025-3-26 06:27 作者: Fibrinogen 時(shí)間: 2025-3-26 12:22
Book 2018enters and countries worldwide. The book also provides guidelines for existing transplantation units to upgrade their practice and implement new policies and procedures, in addition to developing therapies according to latest international standards and regulations..The book covers a wide range of p作者: 條約 時(shí)間: 2025-3-26 15:53 作者: 歡樂(lè)中國(guó) 時(shí)間: 2025-3-26 18:08 作者: BOAST 時(shí)間: 2025-3-26 22:39
https://doi.org/10.1057/9780230299009ance on the recommended practices for key aspects of supportive care and their implementation in a new transplant unit, including intravenous access, intensive care, antiemetic and pain relief, management of mucositis, nutritional support, drug toxicity, and anti-infective management.作者: 個(gè)人長(zhǎng)篇演說(shuō) 時(shí)間: 2025-3-27 04:10 作者: 姑姑在炫耀 時(shí)間: 2025-3-27 08:04
d laboratory analyses improve the safety of blood products and allow appropriate donor selection, thus avoiding blood-transmissible diseases. To reduce relapse risk after HSCT, the assessment of minimal residual disease enables timely therapeutic measures to be taken to eradicate malignant cells in the long term.作者: CLEAR 時(shí)間: 2025-3-27 10:53 作者: 美麗的寫(xiě) 時(shí)間: 2025-3-27 14:17
Transfusion,donor is generally high, approximately 40–50%. Immune-related hemolysis is a commonly encountered complication. In this chapter, we focus on practical guides for the selection and management of the transfusion products required in HSCT from an ABO or Rh blood type–incompatible donor. Practical examples, Tables, and a Format are provided.作者: cavity 時(shí)間: 2025-3-27 20:24
Laboratory Support,d laboratory analyses improve the safety of blood products and allow appropriate donor selection, thus avoiding blood-transmissible diseases. To reduce relapse risk after HSCT, the assessment of minimal residual disease enables timely therapeutic measures to be taken to eradicate malignant cells in the long term.作者: 考博 時(shí)間: 2025-3-27 22:34 作者: overrule 時(shí)間: 2025-3-28 02:20
978-3-319-86606-2Springer International Publishing AG 2018作者: condescend 時(shí)間: 2025-3-28 07:24
Timothy J. Ellender,Joseph R. Shiber0 years to arrive at this point, with many setbacks occurring along the way. Today, absolute transplant numbers and transplant rates (TR; number of HSCTs per number of inhabitants) vary significantly between centers, countries, and global regions. Recent investigations have shed light on some factor作者: 爭(zhēng)吵加 時(shí)間: 2025-3-28 13:17
https://doi.org/10.1007/978-94-009-6036-7000 patients per year, and worldwide activity continues to increase steadily. For many hematological and non-hematological diseases HSCT remains the only curative treatment option. Improved understanding of the immunological mechanisms of tolerance and anti-tumor reactivity has markedly reduced tran作者: 核心 時(shí)間: 2025-3-28 18:38 作者: 散布 時(shí)間: 2025-3-28 22:35
Organisational design and changeristics that allow care of patients with respect to their safety and comfort and according to the standards issued by a national regulatory body or scientific association. The ratio of nurse and patient beds may vary according to the type of patient, type of transplant, type of conditioning regimen,作者: HOWL 時(shí)間: 2025-3-29 00:04 作者: 旅行路線 時(shí)間: 2025-3-29 03:37 作者: RACE 時(shí)間: 2025-3-29 10:25 作者: 展覽 時(shí)間: 2025-3-29 12:02 作者: chalice 時(shí)間: 2025-3-29 19:07 作者: mettlesome 時(shí)間: 2025-3-29 20:48 作者: 殘酷的地方 時(shí)間: 2025-3-30 03:44
Luisa Martín Rojo,Concepción Gómez Estebanhieve this, the critical processes performed in any stem cell processing facility are:.In order to achieve this aim, the establishment of a robust stem cell processing facility requires careful planning of the building and design, including an understanding of the anticipated clinical workload and t作者: 培養(yǎng) 時(shí)間: 2025-3-30 05:15 作者: 推遲 時(shí)間: 2025-3-30 10:43 作者: subordinate 時(shí)間: 2025-3-30 15:52 作者: hypertension 時(shí)間: 2025-3-30 19:52
Theresa Catalano,Linda R. Waughe hematopoietic stem cell transplantation setting, regulatory developments alongside pioneering initiatives led by the professional associations over the past 20years have made quality management a fundamental part of transplantation. However, the resources necessary to develop and maintain an effec作者: Epithelium 時(shí)間: 2025-3-30 21:47 作者: 不成比例 時(shí)間: 2025-3-31 03:11
Introduction: Critically Distant,n recent years was only possible because of the development of high-quality international registries, such as the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR), which provided innumerable studies on HSCT in作者: 長(zhǎng)處 時(shí)間: 2025-3-31 05:34
https://doi.org/10.1007/978-3-031-35561-5es in developing countries, such a program has to compete with other basic healthcare service priorities for the allocation of funds. While working on establishing an HSCT program in a developing country, one should take into consideration several problematic issues, the main ones being financial, l作者: 丑惡 時(shí)間: 2025-3-31 11:06 作者: foreign 時(shí)間: 2025-3-31 15:53
https://doi.org/10.1007/978-3-319-59358-6ABO blood typing; blood marrow; donor safety; multiple myeloma; myeloproliferative disorders; sickle cell作者: 感情脆弱 時(shí)間: 2025-3-31 20:31 作者: 沉積物 時(shí)間: 2025-4-1 00:19
http://image.papertrans.cn/e/image/315744.jpg作者: 使痛苦 時(shí)間: 2025-4-1 04:07
Timothy J. Ellender,Joseph R. Shiber the HSCT procedure add to these differences. The aim of the transplant procedure itself is the same for all: HSCT should provide a better outcome for the individual patient regarding overall survival, quality of life, and costs. Information about their own macro- and microeconomic backgrounds will 作者: Cumulus 時(shí)間: 2025-4-1 06:04 作者: alcoholism 時(shí)間: 2025-4-1 10:24
Organisational design and changering drinking water. To prevent hospital fungal disease, HSCT patients need to be placed in a protective environment equipped with a high-efficiency particulate air (HEPA) filter and positive-pressure room air. For airborne infectious diseases such as influenza or varicella, a positive-pressure room作者: 議程 時(shí)間: 2025-4-1 16:56
